Analysis of health related quality of life (HRQoL) of patients with clinically localized prostate cancer, one year after treatment with external beam radiotherapy (EBRT) alone versus EBRT and high dose rate brachytherapy (HDRBT).

Joseph KJ, Alvi R, Skarsgard D, Tonita J, Pervez N, Small C, Tai P.

Radiat Oncol. 2008 Jul 15;3:20.

PMID: 18627617 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

A prospective quality-of-life study in men with clinically localized prostate carcinoma treated with radical prostatectomy, external beam radiotherapy, or interstitial brachytherapy.

Lee WR, Hall MC, McQuellon RP, Case LD, McCullough DL.

Int J Radiat Oncol Biol Phys. 2001 Nov 1;51(3):614-23.

PMID: 11597800 [PubMed - indexed for MEDLINE]

Related Articles

Acute genitourinary toxicity after high-dose-rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.

Akimoto T, Ito K, Saitoh J, Noda SE, Harashima K, Sakurai H, Nakayama Y, Yamamoto T, Suzuki K, Nakano T, Niibe H.

Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):463-71.

PMID: 16168838 [PubMed - indexed for MEDLINE]

Related Articles

Interim report of image-guided conformal high-dose-rate brachytherapy for patients with unfavorable prostate cancer: the William Beaumont phase II dose-escalating trial.

Martinez AA, Kestin LL, Stromberg JS, Gonzalez JA, Wallace M, Gustafson GS, Edmundson GK, Spencer W, Vicini FA.

Int J Radiat Oncol Biol Phys. 2000 May 1;47(2):343-52.

PMID: 10802358 [PubMed - indexed for MEDLINE]

Related Articles

A preliminary analysis of health-related quality of life in the first year after permanent source interstitial brachytherapy (PIB) for clinically localized prostate cancer.

Lee WR, McQuellon RP, Harris-Henderson K, Case LD, McCullough DL.

Int J Radiat Oncol Biol Phys. 2000 Jan 1;46(1):77-81.

PMID: 10656376 [PubMed - indexed for MEDLINE]

Related Articles

Radical prostatectomy, external beam radiotherapy <72 Gy, external beam radiotherapy > or =72 Gy, permanent seed implantation, or combined seeds/external beam radiotherapy for stage T1-T2 prostate cancer.

Kupelian PA, Potters L, Khuntia D, Ciezki JP, Reddy CA, Reuther AM, Carlson TP, Klein EA.

Int J Radiat Oncol Biol Phys. 2004 Jan 1;58(1):25-33.

PMID: 14697417 [PubMed - indexed for MEDLINE]

Related Articles

Health-related quality of life in men after treatment of localized prostate cancer with external beam radiotherapy combined with (192)ir brachytherapy: a prospective study of 93 cases using the EORTC questionnaires QLQ-C30 and QLQ-PR25.

Wahlgren T, Brandberg Y, Häggarth L, Hellström M, Nilsson S.

Int J Radiat Oncol Biol Phys. 2004 Sep 1;60(1):51-9.

PMID: 15337539 [PubMed - indexed for MEDLINE]

Related Articles

Quality of life of men treated with brachytherapies for prostate cancer.

Lev EL, Eller LS, Gejerman G, Lane P, Owen SV, White M, Nganga N.

Health Qual Life Outcomes. 2004 Jun 15;2:28.

PMID: 15198803 [PubMed - indexed for MEDLINE]

Related Articles Free article in PMC

Radical prostatectomy versus high-dose rate brachytherapy for prostate cancer: effects on health-related quality of life.

Jo Y, Junichi H, Tomohiro F, Yoshinari I, Masato F.

BJU Int. 2005 Jul;96(1):43-7.

PMID: 15963118 [PubMed - indexed for MEDLINE]

Related Articles

Unification of a common biochemical failure definition for prostate cancer treated with brachytherapy or external beam radiotherapy with or without androgen deprivation.

Fitch DL, McGrath S, Martinez AA, Vicini FA, Kestin LL.

Int J Radiat Oncol Biol Phys. 2006 Dec 1;66(5):1430-9. Epub 2006 Jun 12.

PMID: 16765527 [PubMed - indexed for MEDLINE]

Related Articles

High dose rate iridium-192 brachytherapy as a component of radical radiotherapy for the treatment of localised prostate cancer.

Chin YS, Bullard J, Bryant L, Bownes P, Ostler P, Hoskin PJ.

Clin Oncol (R Coll Radiol). 2006 Aug;18(6):474-9.

PMID: 16909971 [PubMed - indexed for MEDLINE]

Related Articles

Quality of life study in prostate cancer patients treated with three-dimensional conformal radiation therapy: comparing late bowel and bladder quality of life symptoms to that of the normal population.

Hanlon AL, Watkins Bruner D, Peter R, Hanks GE.

Int J Radiat Oncol Biol Phys. 2001 Jan 1;49(1):51-9. Review.

PMID: 11163497 [PubMed - indexed for MEDLINE]

Related Articles

Clinical results of combined treatment conformal high-dose-rate iridium-192 brachytherapy and external beam radiotherapy using staging lymphadenectomy for localized prostate cancer.

Hiratsuka J, Jo Y, Yoshida K, Nagase N, Fujisawa M, Imajo Y.

Int J Radiat Oncol Biol Phys. 2004 Jul 1;59(3):684-90.

PMID: 15183471 [PubMed - indexed for MEDLINE]

Related Articles

Acute genitourinary toxicity after high dose rate (HDR) brachytherapy combined with hypofractionated external-beam radiation therapy for localized prostate cancer: Second analysis to determine the correlation between the urethral dose in HDR brachytherapy and the severity of acute genitourinary toxicity.

Akimoto T, Katoh H, Noda SE, Ito K, Yamamoto T, Kashiwagi B, Nakano T.

Int J Radiat Oncol Biol Phys. 2005 Oct 1;63(2):472-8.

PMID: 16168839 [PubMed - indexed for MEDLINE]

Related Articles

Matched-pair analysis of conformal high-dose-rate brachytherapy boost versus external-beam radiation therapy alone for locally advanced prostate cancer.

Kestin LL, Martinez AA, Stromberg JS, Edmundson GK, Gustafson GS, Brabbins DS, Chen PY, Vicini FA.

J Clin Oncol. 2000 Aug;18(15):2869-80.

PMID: 10920135 [PubMed - indexed for MEDLINE]

Related Articles

Potency probability following conformal megavoltage radiotherapy using conventional doses for localized prostate cancer.

Mantz CA, Song P, Farhangi E, Nautiyal J, Awan A, Ignacio L, Weichselbaum R, Vijayakumar S.

Int J Radiat Oncol Biol Phys. 1997 Feb 1;37(3):551-7.

PMID: 9112452 [PubMed - indexed for MEDLINE]

Related Articles

Changing trends in national practice for external beam radiotherapy for clinically localized prostate cancer: 1999 Patterns of Care survey for prostate cancer.

Zelefsky MJ, Moughan J, Owen J, Zietman AL, Roach M 3rd, Hanks GE.

Int J Radiat Oncol Biol Phys. 2004 Jul 15;59(4):1053-61.

PMID: 15234039 [PubMed - indexed for MEDLINE]

Related Articles

Early quality of life assessment in men treated with permanent source interstitial brachytherapy for clinically localized prostate cancer.

Lee WR, McQuellon RP, Case LD, deGuzman AF, McCullough DL.

J Urol. 1999 Aug;162(2):403-6.

PMID: 10411047 [PubMed - indexed for MEDLINE]

Related Articles

Association of percent positive prostate biopsies and perineural invasion with biochemical outcome after external beam radiotherapy for localized prostate cancer.

Wong WW, Schild SE, Vora SA, Halyard MY.

Int J Radiat Oncol Biol Phys. 2004 Sep 1;60(1):24-9.

PMID: 15337536 [PubMed - indexed for MEDLINE]

Related Articles

Comparison of the outcome and morbidity for localized or locally advanced prostate cancer treated by high-dose-rate brachytherapy plus external beam radiotherapy (EBRT) versus EBRT alone.

Fang FM, Wang YM, Wang CJ, Huang HY, Chiang PH.

Jpn J Clin Oncol. 2008 Jul;38(7):474-9. Epub 2008 Jul 11.

PMID: 18621848 [PubMed - indexed for MEDLINE]

Related Articles